Monte Rosa Therapeutics
GLUE
#7806
Rank
$0.24 B
Marketcap
$3.95
Share price
1.54%
Change (1 day)
-44.13%
Change (1 year)

Operating Margin for Monte Rosa Therapeutics (GLUE)

Operating Margin as of April 2025 (TTM): -92.73%

According to Monte Rosa Therapeutics's latest financial reports and stock price the company's current Operating Margin is -92.73%. At the end of 2024 the company had an Operating Margin of -92.74%.

Operating Margin history for Monte Rosa Therapeutics from 2024 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2024-92.74%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.